TABLE 4.

Recommended Weight-Based Dosing Guidance on Administered Activities Based on Patient Weight

ScanRadiopharmaceuticalMBq/kg
PET (tumor)18F-FDG5.18
PET (brain)18F-FDG3.7
PET18F-NaF2.22
PET68Ga (DOTATATE/PSMA)1.85
Gated blood pool99mTc-RBC8.14
MPI rest99mTc-tetrofosmin, MIBI10.73
MPI stress99mTc-tetrofosmin, MIBI10.73
Renal99mTc-DMSA1.85
Renal99mTc-DTPA (GFR)2.59
Renal99mTc-MAG33.7
Bone99mTc-methyl diphosphonate9.25
Brain99mTc-HMPAO2.775
Gastrointestinal67Ga-citrate1.85
Esophageal reflux99mTc-DTPA0.37
Hepatobiliary99mTc-HIDA1.85
Lung perfusion99mTc-MAA2.59
Parathyroid99mTc-MIBI, tetrofosmin5.55
Salivary gland99mTc-pertechnetate1.11
Testicular99mTc-pertechnetate7.4
Thyroid131I-iodide0.555
Thyroid99mTc-pertechnetate1.11
Gastric emptying99mTc-DTPA0.37
Meckel diverticulum99mTc-pertechnetate1.85
Renal cystogram99mTc-pertechnetate0.37
Infection67Ga-citrate1.11
Infection99mTc-WBC (colloid/HMPAO)27.75
Lymphoscintigraphy99mTc-nanocolloid0.259
CSF leak99mTc-DTPA2.59
CSF shunt patency99mTc-pertechnetate + 99mTc, DTPA0.259
  • PSMA = prostate-specific membrane antigen; RBC = red blood cell; MPI = myocardial perfusion imaging; MIBI = methoxyisobutylisonitrile; DMSA = dimercaptosuccinic acid; DTPA = diethylenetriamine pentaacetic acid; GFR = glomerular filtration rate; MAG3 = mercaptoacetyltriglycine; HMPAO = hexamethylpropyleneamine oxime; HIDA = hepatobiliary iminodiacetic acid; WBC = white blood cell; MAA = macroaggregated albumin; CSF = cerebrospinal fluid.